CASE REPORT
Severe hyperphosphataemia and metabolic acidosis after administration of phosphate-containing enema in a 10-year-old girl – case report and review of literature
 
More details
Hide details
1
Students’ Scientific Association of Paediatric Gastroenterology, Department of Paediatrics, Haemato-Oncology, and Gastroenterology, Pomeranian Medical University, Szczecin, Poland
 
2
Department of Paediatrics, Haemato-Oncology, and Gastroenterology, Pomeranian Medical University, Szczecin, Poland
 
 
Submission date: 2020-10-02
 
 
Final revision date: 2020-11-08
 
 
Acceptance date: 2020-11-25
 
 
Publication date: 2021-01-30
 
 
Pediatr Pol 2020;95(4):258-262
 
KEYWORDS
TOPICS
ABSTRACT
Constipation is among the most common complaints in GPs’ offices, affecting over 10% of children reporting to the doctor [1]. Due to the COVID-19 pandemic, access to specialist care has become difficult, which has led to neglect of diagnosis and managing chronic diseases. We present a case of a 10-year-old girl admitted to the emergency department (ED) with symptoms of severe constipation and abdominal pain and a history of ongoing constipation and faecal soiling for 6 months. In the ED she was given a sodium-phosphate enema twice. After a few hours she developed life-threatening hyperphosphataemia, hypocalcaemia, and metabolic acidosis. The presented patient presents an example of severe, chronic, and improperly treated constipation with an extremely rare side effect of a sodium-phosphate enema. It is important to underline that monitoring after the procedure and quick and proper treatment, if the mentioned effect occurs, can save the patient’s life.
REFERENCES (27)
1.
XiniasI, Mavroudi A. Constipation in childhood. An update on evaluation and management. Hippokratia 2015; 19: 11-19.
 
2.
Rubin G, Dale A. Chronic constipation in children. BMJ 2006; 333: 1051-1055.
 
3.
Arya S, Gupta N, Gupta R, et al. Constipation and outcomes of cecostomy, Am J Ther 2016; 23: 1867-1875.
 
4.
Maerzheuser S, Bassir C, Rothe K. Hirschsprung disease in the older child. Clin Pediatr 2012; 51: 1087-1090.
 
5.
Czerwionka-Szaflarska M, Romańczuk B. Postępowanie w zaparciu czynnościowym stolca u dzieci i młodzieży. Forum Med Rodz 2008; 2: 349-357.
 
6.
Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 2014; 58: 258-274.
 
7.
Russo M, Strisciuglio C, Scarpato E, et al. Functional chronic constipation: Rome III criteria versus rome IV criteria, J Neuro Gastroenterol Motil 2019; 25: 123-128.
 
8.
Hyams J, Colletti R, Faure C, et al. Functional gastrointestinal disorders: working group report of the first world Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2002; 35: 110-117.
 
9.
Bokhari SR, Siriki R, Teran FJ, et al. Fatal hypermagnesemia due to laxative use. Am J Med Sci 2018; 355: 390-395.
 
10.
Nutter I. Meckler G, Truong M, et al. Constipation and paediatric emergency department utilization. Paediatr Child Health 2017; 22: 139-142.
 
11.
Medycyna Praktyczna Online. https://www.mp.pl/pacjent/leki..., 10.07.2020.
 
12.
Becknell B, Smoyer WE, O’Brien NF. Hemodialysis for near-fatal sodium phosphate toxicity in a child receiving sodium phosphate enemas. Pediatr Emerg Care 2014; 30: 14-817.
 
13.
Cohan CF, Kadakia SC, Kadakia AS. Serum electrolyte, mineral, and blood pH changes after phosphate enema, water enema, and electrolyte lavage solution enema for flexible sigmoidoscopy. Gastrointest Endosc 1992; 38: 575-578.
 
14.
Hamid R. Hajmomenian, severe hypocalcemia and hyperphosphatemia after fleet enema administration. Proceedings UCLA Healthcare 2013; 17.
 
15.
Ladenhauf HN, Stundner O, Spreitzhofer F, et al. Severe hyperphosphatemia after administration of sodium-phosphate containing laxatives in children: case series and systematic review of literature, Pediatr Surg Int 2012; 28: 805-814.
 
16.
Mendoza J, Legido J, Rubio S, et al. Systematic review: the adverse effects of sodium phosphate enema. Aliment Pharmacol Ther 2007; 26: 9-20.
 
17.
Núñez Sánchez MJ, Leighton Swaneck S, Díaz F. Tetaniaseveraporuso de enemas fosfatados, reporte de caso. Revista Chilena Pediatría 2017; 88: 383-387.
 
18.
Jacobson RM, Peery J, Thompson WO, et al. Serum electrolyte shifts following administration of sodium phosphates enema. Gastroenterol Nurs 2010; 33: 191-201.
 
19.
Wason S, Tiller T, Cunha C. Severe hyperphosphatemia, hypocalcemia, acidosis, and shock in a 5-month-old child following the administration of an adult fleet enema. Ann Emerg Med 1989; 18: 696-700.
 
20.
Gattineni J, Baum M. Genetic disorders of phosphate regulation. Pediatr Nephrol 2012; 27: 1477-1487.
 
21.
Poddar U. Approach to constipation in children. Indian Pediatr 2016; 53: 319-327.
 
22.
Koppen IJN, Broekaert IJ, Wilschanski M, et al. Role of polyethylene glycol in the treatment of functional constipation in children. J Pediatr Gastroenterol Nutr 2017; 65: 361-363.
 
23.
Lyseng-Williamson K. Macrogol (polyethylene glycol) 4000 without electrolytes in the symptomatic treatment of chronic constipation: a profile of its use. Drug Therapy Perspect 2018; 34: 1-11.
 
24.
Portnoy J, Waller M, Elliott T. Telemedicine in the era of COVID-19. J Allergy Clin Immunol Pract 2020; 8: 1489-1491.
 
25.
Burke BL, Hall RW. Telemedicine: pediatric applications. Pediatr 2015; 136: 293-308.
 
26.
Miller H, Panahi L, Tapia D, et al. Loperamide misuse and abuse. J Am Pharm Assoc 2017; 57: 45-50.
 
27.
Wu PE, Juurlink DN. Clinical review: loperamidetoxicity. Ann Emerg Med 2017; 70: 245-252.
 
Journals System - logo
Scroll to top